Display options
Cite
Zoeller RT, Brown TR, Doan LL, et al. Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology. 2012;153(9):4097-110doi: 10.1210/en.2012-1422.
Zoeller, R. T., Brown, T. R., Doan, L. L., Gore, A. C., Skakkebaek, N. E., Soto, A. M., Woodruff, T. J., & Vom Saal, F. S. (2012). Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology, 153(9), 4097-110. https://doi.org/10.1210/en.2012-1422
Zoeller, R Thomas, et al. "Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society." Endocrinology vol. 153,9 (2012): 4097-110. doi: https://doi.org/10.1210/en.2012-1422
Zoeller RT, Brown TR, Doan LL, Gore AC, Skakkebaek NE, Soto AM, Woodruff TJ, Vom Saal FS. Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology. 2012 Sep;153(9):4097-110. doi: 10.1210/en.2012-1422. Epub 2012 Jun 25. PMID: 22733974; PMCID: PMC3423612.
Copy Download .nbib Format: NLM
Share it on

Endocrinology. 2012 Sep;153(9):4097-110. doi: 10.1210/en.2012-1422. Epub 2012 Jun 25.

Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society.

Endocrinology

R Thomas Zoeller, T R Brown, L L Doan, A C Gore, N E Skakkebaek, A M Soto, T J Woodruff, F S Vom Saal

Affiliations

  1. Biology Department, University of Massachusetts, 611 North Pleasant Street, Amherst, Massachusetts 01003, USA. [email protected]

PMID: 22733974 PMCID: PMC3423612 DOI: 10.1210/en.2012-1422

Abstract

An endocrine-disrupting chemical (EDC) is an exogenous chemical, or mixture of chemicals, that can interfere with any aspect of hormone action. The potential for deleterious effects of EDC must be considered relative to the regulation of hormone synthesis, secretion, and actions and the variability in regulation of these events across the life cycle. The developmental age at which EDC exposures occur is a critical consideration in understanding their effects. Because endocrine systems exhibit tissue-, cell-, and receptor-specific actions during the life cycle, EDC can produce complex, mosaic effects. This complexity causes difficulty when a static approach to toxicity through endocrine mechanisms driven by rigid guidelines is used to identify EDC and manage risk to human and wildlife populations. We propose that principles taken from fundamental endocrinology be employed to identify EDC and manage their risk to exposed populations. We emphasize the importance of developmental stage and, in particular, the realization that exposure to a presumptive "safe" dose of chemical may impact a life stage when there is normally no endogenous hormone exposure, thereby underscoring the potential for very low-dose EDC exposures to have potent and irreversible effects. Finally, with regard to the current program designed to detect putative EDC, namely, the Endocrine Disruptor Screening Program, we offer recommendations for strengthening this program through the incorporation of basic endocrine principles to promote further understanding of complex EDC effects, especially due to developmental exposures.

References

  1. Environ Health Perspect. 2009 Jun;117(6):910-5 - PubMed
  2. Endocrinology. 2006 Jun;147(6 Suppl):S56-69 - PubMed
  3. J Biol Chem. 2011 Apr 15;286(15):12971-82 - PubMed
  4. Environ Health Perspect. 2010 Nov;118(11):1614-9 - PubMed
  5. Endocrinology. 2011 Apr;152(4):1640-51 - PubMed
  6. Environ Health Perspect. 1998 Feb;106 Suppl 1:171-89 - PubMed
  7. PLoS One. 2008;3(11):e3745 - PubMed
  8. Environ Health Perspect. 2007 Jan;115(1):80-6 - PubMed
  9. Int J Androl. 2006 Feb;29(1):140-7; discussion 181-5 - PubMed
  10. Environ Health Perspect. 1996 Aug;104 Suppl 4:715-40 - PubMed
  11. Ind Health. 2010;48(1):115-8 - PubMed
  12. J Toxicol Environ Health B Crit Rev. 2009 Apr;12(4):225-49 - PubMed
  13. Front Neuroendocrinol. 2010 Oct;31(4):395-9 - PubMed
  14. Nature. 2010 Apr 22;464(7292):1122-4 - PubMed
  15. Thyroid Res. 2009 Mar 31;2(1):3 - PubMed
  16. Endocr Relat Cancer. 2010 Feb 25;17(2):R91-107 - PubMed
  17. Mol Endocrinol. 2009 Aug;23(8):1231-41 - PubMed
  18. Nat Rev Endocrinol. 2011 Jun;7(6):346-53 - PubMed
  19. Endocrinology. 2011 Jul;152(7):2909-19 - PubMed
  20. Nat Rev Endocrinol. 2011 Apr;7(4):197-207 - PubMed
  21. Environ Health Perspect. 2010 Sep;118(9):1243-50 - PubMed
  22. Environ Health Perspect. 2011 May;119(5):641-6 - PubMed
  23. J Toxicol Environ Health B Crit Rev. 2009 Feb;12(2):157-74 - PubMed
  24. Toxicol Sci. 2009 Aug;110(2):411-25 - PubMed
  25. Crit Rev Toxicol. 2007 Jan-Feb;37(1-2):55-95 - PubMed
  26. Endocrinology. 1993 Jun;132(6):2287-92 - PubMed
  27. Environ Health Perspect. 2008 Sep;116(9):1231-6 - PubMed
  28. Environ Health Perspect. 2006 Jun;114(6):898-904 - PubMed
  29. Br J Pharmacol. 2009 Sep;158(1):165-8 - PubMed
  30. Endocr Rev. 2012 Jun;33(3):378-455 - PubMed
  31. Toxicol In Vitro. 2012 Apr;26(3):526-34 - PubMed
  32. Toxicol Pathol. 2001 Jan-Feb;29(1):34-40 - PubMed
  33. Circulation. 2012 Mar 27;125(12):1482-90 - PubMed
  34. Reprod Toxicol. 2007 Apr-May;23(3):383-90 - PubMed
  35. Environ Health Perspect. 2011 Feb;119(2):168-75 - PubMed
  36. Toxicol Sci. 2009 Sep;111(1):163-78 - PubMed
  37. Environ Res. 2006 Jan;100(1):93-9 - PubMed
  38. Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):12033-8 - PubMed
  39. Toxicol Sci. 2010 May;115(1):1-11 - PubMed
  40. Neurotoxicology. 2012 Aug;33(4):842-52 - PubMed
  41. Environ Health Perspect. 2009 Jun;117(6):879-85 - PubMed
  42. Rev Environ Health. 2006 Jan-Mar;21(1):1-23 - PubMed
  43. Environ Health Perspect. 2011 Nov;119(11):1604-9 - PubMed
  44. Environ Health Perspect. 1989 May;81:225-39 - PubMed
  45. Pharm World Sci. 2005 Jun;27(3):139-43 - PubMed
  46. Birth Defects Res B Dev Reprod Toxicol. 2011 Oct;92(5):413-20 - PubMed
  47. J Toxicol Environ Health B Crit Rev. 1998 Jan-Mar;1(1):27-58 - PubMed
  48. Mol Cell Endocrinol. 2006 Sep 26;257-258:26-34 - PubMed
  49. Environ Res. 2006 Jan;100(1):50-76 - PubMed
  50. Environ Health Perspect. 1999 Feb;107(2):155-9 - PubMed
  51. Endocrinology. 2007 Jul;148(7):3185-95 - PubMed
  52. Endocr Rev. 2009 Jun;30(4):293-342 - PubMed
  53. J Toxicol Sci. 2012 Feb;37(1):33-49 - PubMed
  54. Risk Anal. 1999 Apr;19(2):231-47 - PubMed
  55. Environ Health Perspect. 2002 Sep;110(9):917-21 - PubMed
  56. PLoS One. 2008 Apr 30;3(4):e2069 - PubMed
  57. Environ Health Perspect. 2003 Jun;111(8):994-1006 - PubMed
  58. Dev Biol. 2009 Oct 15;334(2):429-36 - PubMed
  59. PLoS One. 2012;7(2):e31109 - PubMed
  60. Regul Toxicol Pharmacol. 2011 Apr;59(3):397-411 - PubMed
  61. Environ Health Perspect. 2008 Mar;116(3):322-8 - PubMed
  62. Toxicol Appl Pharmacol. 1999 Oct 15;160(2):163-70 - PubMed
  63. Biol Reprod. 2011 Apr;84(4):734-42 - PubMed
  64. Eur J Cancer Clin Oncol. 1987 Dec;23(12):1935-9 - PubMed
  65. Basic Clin Pharmacol Toxicol. 2008 Feb;102(2):125-33 - PubMed

Substances

MeSH terms

Publication Types

Grant support